Evidence map›Paper›PMID 34463573›Full record

ArticlemSystems2021

Dominant Bacterial Phyla from the Human Gut Show Widespread Ability To Transform and Conjugate Bile Acids.

L N Lucas, K Barrett, R L Kerby, Q Zhang, L E Cattaneo, D Stevenson, F E Rey, D Amador-Noguez

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
23.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 1 synthesis or guideline pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Expanding bile acid diversityNatural product reports · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Alkamines reveal a hidden layer of steroid and drug metabolism.bioRxiv : the preprint server for biology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

L N LucasDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
K BarrettDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
R L KerbyDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Q ZhangDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
L E CattaneoDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
D StevensonDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
F E ReyDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
D Amador-NoguezDepartment of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-3568-3070
University of Wisconsin–Madison · US

Funding

BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
Biotechnology Training ProgramT32GM135066 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI SCOTT M. COYLE, BRIAN G FOX · 2020 to 2026
$7.0M
Collaborative Cross of the Microbiome and Metabolic DiseaseR01DK108259 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI REY, FEDERICO E · 2015 to 2019
$2.1M
Fondation Leducq Transatlantic Networks of Excellence AwardHHS | National Institutes of Health (NIH) DK108259HHS | NIH | National Institute of General Medical Sciences (NIGMS) T32GM008349National Science Foundation (NSF) 1715710NIDDK NIH HHS R01 DK108259NIGMS NIH HHS T32 GM008349NIGMS NIH HHS T32 GM135066University of Wisconsin-Madison (UW) SciMed Grauate Research Scholars Fellowship
6 · The paper itself

Abstract

Gut bacteria influence human physiology by chemically modifying host-synthesized primary bile acids. These modified bile acids, known as secondary bile acids, can act as signaling molecules that modulate host lipid, glucose, and energy metabolism and affect gut microbiota composition via selective antimicrobial properties. However, knowledge regarding the bile acid-transforming capabilities of individual gut microbes remains limited. To help address this knowledge gap, we screened 72 bacterial isolates, spanning seven major phyla commonly found in the human gut, for their ability to chemically modify unconjugated bile acids. We found that 43 isolates, representing 41 species, were capable of

Indexed as

bile acidsconjugationgut bacteriamass spectrometrymicrobially conjugated bile acidsmicrobiome

Identifiers

PMID34463573
PMCPMC12338150
OpenAlexW3198649369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.